Key Takeaways
- Diabetes can build for years before a person gets diagnosed.
- Early signs often include thirst, urination, fatigue, and blurry vision.
- Numb feet, slow healing, and repeat infections can be warning signs.
- Fatty liver and high ferritin may point to deeper metabolic trouble.
- Cutting sugar and starch may improve blood glucose in some adults.
Diabetes often starts quietly. A person may feel off for months, or even years, before the pattern is clear. The red flags are not just about sugar. They can also show up in the eyes, nerves, liver, and even iron handling. (PubMed)
Classic Signs
Thirst
One of the clearest signs is needing to urinate more often, along with strong thirst. This can happen when blood glucose rises and the body tries to clear some of that extra glucose through urine. The fluid loss can leave a person dry, tired, and thirsty again soon after drinking (NIDDK, 2025)
Fatigue
Diabetes can also show up as deep tiredness, more hunger than usual, or weight loss that does not make sense. When glucose is high in the blood but not moving well into cells, the body may struggle to meet its energy needs. That can leave a person drained, even after eating (CDC, 2024).
Blurred Vision
Blurred vision, cuts that heal slowly, repeat skin or yeast infections, and tingling or numbness in the hands or feet also belong on the list.
Nerve injury is a known complication of diabetes, and long-term high glucose is also tied to eye disease and retinal damage (Tesfaye et al., 2010 Yau et al., 2012).
Silent Build-Up
Years Before Diagnosis
Type 2 diabetes rarely begins on the day of diagnosis. An older but still important study found that it may start at least 4 to 7 years before clinical diagnosis, which helps explain why some people already have complications when diabetes is first found (Harris et al., 1992).
That long quiet phase is one reason the early signs matter. A person may blame thirst on heat, blame fatigue on work, or blame blurry vision on age. The body may already be under strain.
Fatty Liver Clues
A fatty liver can be part of that early picture. It often travels with insulin resistance, high blood glucose, and high triglycerides. In some people, a liver ultrasound or blood test changes may show up before diabetes is diagnosed. This matters because fatty liver is tied to more than stored fat alone. Research also discusses disturbed iron and copper handling in nonalcoholic fatty liver disease, which suggests that mineral balance may be woven into the disease process (Aigner et al., 2015).
Iron & Oxidative Stress
Ferritin & Insulin Resistance
Iron overload keeps showing up next to insulin resistance and type 2 diabetes risk. In prospective and clinical work, higher ferritin and other markers of body iron stores have been linked with poorer glucose handling and greater diabetes risk (Rajpathak et al., 2009 Fernández-Real et al., 1998).
That does not mean every person with a high ferritin level has diabetes. Ferritin can rise for other reasons too, such as inflammation.
Still, when high ferritin appears together with central weight gain, fatty liver, and rising glucose, it may be a useful red flag rather than a side note.
Iron, Liver Fat & Oxidative Stress
Iron may also help explain why some people with fatty liver become more insulin resistant than others. In one study, liver fat and insulin sensitivity varied in part with iron load (Haap et al., 2011).
A later review described broad links between iron metabolism, insulin resistance, and fatty liver (Krisai et al., 2016).
One likely bridge is oxidative stress, which means excess chemical stress from reactive molecules that can injure cells. Reviews and clinical papers have linked higher iron stores with oxidative stress and insulin resistance, giving a possible mechanism rather than a simple overlap (Rajpathak, 2009 Huang et al., 2015).
Food & Daily Pattern
Carbohydrate Load
When diabetes or prediabetes is suspected, food pattern matters. A short clinical trial in adults with type 2 diabetes found that a low-carbohydrate diet improved 24-hour blood glucose, insulin sensitivity, hemoglobin A1c, and triglycerides over two weeks (Boden et al., 2005).
A widely cited review then argued that carbohydrate restriction deserves serious use as a first-line option in diabetes care because it reliably lowers high blood glucose, the main feature of diabetes (Feinman et al., 2015).
That does not mean one exact diet fits every person. It does mean that lower sugar and starch intake can be a practical part of the picture for many adults. (PubMed)
Other Exposures
Other exposures may matter too, but the evidence is less settled. One review argued that some medicines and vegetable oils may add to diabetes and heart disease risk, though this remains debated and should be read with care (Okuyama et al., 2016).
Pregnancy adds another layer. A prospective study reported that some metal patterns before 24 weeks of pregnancy were linked with later glucose changes and gestational diabetes risk (Zhou et al., 2021). This suggests that the metabolic story can include the environment as well as diet.
When To Check
Who Should Act Now
A person should take symptoms seriously when thirst, frequent urination, blurred vision, numb feet, slow healing, or sudden weight change start to cluster. These signs deserve attention even when they seem mild.
Screening also matters because many people have few symptoms. Public health and diabetes groups list increased urination, thirst, hunger, fatigue, blurry vision, infections, and numbness among the common warning signs (ADA, 2026 NIDDK, 2025). (diabetes.org)
What Testing Looks Like
Testing is simple. Diabetes can be checked with fasting glucose, A1c, a two-hour glucose test, or in some cases a random blood glucose when classic symptoms are present. In current diabetes standards, classic symptoms plus a random plasma glucose of 200 mg/dL or higher can support diagnosis (ADA, 2021). (PubMed)
For people with suspected metabolic trouble, the bigger picture may help too. Along with glucose and A1c, clinicians may look at triglycerides, liver markers, waist size, blood pressure, and sometimes ferritin, depending on the case. Those clues can show whether the body is under wider metabolic strain.
Before changing your diet, supplements, or health routine, talk with a licensed healthcare professional. For any health concerns or questions about a medical condition, get guidance from a physician or another appropriately trained clinician.
FAQs
What are the earliest warning signs of diabetes?
The earliest signs often include frequent urination, strong thirst, unusual fatigue, more hunger, and blurry vision. Some people also notice slow healing or repeat infections.
Can diabetes develop without obvious symptoms?
Yes. Type 2 diabetes can build for years with few clear symptoms, which is why screening matters in adults with risk factors.
Does high ferritin mean someone has diabetes?
No. High ferritin can have several causes. Still, when it appears with fatty liver, high triglycerides, and poor glucose control, it may be a useful warning sign.
Can fatty liver be a red flag for diabetes?
Yes. Fatty liver often appears with insulin resistance and can signal wider metabolic trouble that raises diabetes risk.
Can diet improve early diabetes markers?
In many adults, changing food choices can help. Lower carbohydrate intake has improved blood glucose and insulin resistance in clinical studies.
Research
Aigner, E., Weiss, G. and Datz, C., 2015. Dysregulation of iron and copper homeostasis in nonalcoholic fatty liver. World Journal of Hepatology, 7(2), pp.177-188.
American Diabetes Association, 2021. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes. Diabetes Care, 44(Suppl 1).
Boden, G., Sargrad, K., Homko, C., Mozzoli, M. and Stein, T., 2005. Effect of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes. Annals of Internal Medicine, 142(6), pp.403-411.
Feinman, R.D., Pogozelski, W.K., Astrup, A., Bernstein, R.K., Fine, E.J., Westman, E.C., Accurso, A., Frassetto, L. and Gower, B.A., 2015. Dietary carbohydrate restriction as the first approach in diabetes management: Critical review and evidence base. Nutrition, 31(1), pp.1-13.
Fernández-Real, J.M., López-Bermejo, A. and Ricart, W., 1998. Serum ferritin as a component of the insulin resistance syndrome. Diabetes Care, 21(1), pp.62-68.
Haap, M., Machann, J., von Friedeburg, C., Schick, F., Stefan, N., Schwenzer, N.F. and Häring, H.U., 2011. Insulin sensitivity and liver fat: role of iron load. Journal of Clinical Endocrinology and Metabolism, 96(6), pp.E958-E961.
Harris, M.I., Klein, R., Welborn, T.A. and Knuiman, M.W., 1992. Onset of NIDDM occurs at least 4-7 years before clinical diagnosis. Diabetes Care, 15(7), pp.815-819.
Huang, J., Jones, D., Luo, B., Sanderson, M., Soto, J., Abel, E.D., Cooksey, R.C. and McClain, D.A., 2015. Association of insulin resistance with serum ferritin and oxidative stress in type 2 diabetes mellitus. World Journal of Diabetes, 6(4), pp.232-241.
Okuyama, H., Langsjoen, P.H., Ohara, N., Hashimoto, Y., Hamazaki, T., Yoshida, S. and Kobayashi, T., 2016. Medicines and vegetable oils as hidden causes of cardiovascular disease and diabetes. Pharmacology, 98(3-4), pp.134-170.
Rajpathak, S.N., Crandall, J.P., Wylie-Rosett, J., Kabat, G.C., Rohan, T.E. and Hu, F.B., 2009. Biomarkers of body iron stores and risk of developing type 2 diabetes. Diabetes, Obesity and Metabolism, 11(5), pp.472-479.
Tesfaye, S., Boulton, A.J.M., Dyck, P.J., Freeman, R., Horowitz, M., Kempler, P., Lauria, G., Malik, R.A., Spallone, V. and Vinik, A., 2010. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care, 33(10), pp.2285-2293.
Yau, J.W.Y., Rogers, S.L., Kawasaki, R., Lamoureux, E.L., Kowalski, J.W., Bek, T., Chen, S.J., Dekker, J.M., Fletcher, A. and Grauslund, J., 2012. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care, 35(3), pp.556-564.
Zhou, Z., Chen, J., Zhao, D., Wu, X., Wang, X., Wang, H., Zhang, J., Pan, X. and Wang, Y., 2021. Prospective association of metal levels with gestational diabetes mellitus and glucose: A birth cohort study. Environmental Research, 197.
Selvin, E., Parrinello, C.M., Sacks, D.B. and Coresh, J., 2014. Trends in prevalence and control of diabetes in the United States, 1988–1994 and 1999–2010. Annals of Internal Medicine. doi: 10.7326/M13-2411. PMID: 24798513.
Engelgau, M.M., Narayan, K.M.V., Herman, W.H., 2000. Screening for type 2 diabetes. Diabetes Care. doi: 10.2337/diacare.23.10.1563. PMID: 11023153.
Boulton, A.J.M., Vinik, A.I., Arezzo, J.C. et al., 2005. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. doi: 10.2337/diacare.28.4.956. PMID: 15793206.
Fowler, M.J., 2008. Microvascular and macrovascular complications of diabetes. Clinical Diabetes. doi: 10.2337/diaclin.26.2.77.
Forbes, J.M. and Cooper, M.E., 2013. Mechanisms of diabetic complications. Physiological Reviews. doi: 10.1152/physrev.00045.2011. PMID: 23303908.
American Diabetes Association, 2014. Diagnosis and classification of diabetes mellitus. Diabetes Care. doi: 10.2337/dc14-S081. PMID: 24357215.
Nathan, D.M., 2014. Diabetes: advances in diagnosis and treatment. JAMA. doi: 10.1001/jama.2014.16657. PMID: 25536252.
Zimmet, P., Alberti, K.G.M.M., Magliano, D.J. and Bennett, P.H., 2016. Diabetes mellitus statistics on prevalence and mortality: facts and fallacies. Nature Reviews Endocrinology. doi: 10.1038/nrendo.2016.105. PMID: 27329026.
World Health Organization, 2006. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia. Diabetes Research and Clinical Practice.
Polonsky, K.S., 2012. The past 200 years in diabetes. New England Journal of Medicine. doi: 10.1056/NEJMra1110560. PMID: 22296224.
Tabák, A.G., Herder, C., Rathmann, W., Brunner, E.J. and Kivimäki, M., 2012. Prediabetes: a high-risk state for diabetes development. Lancet. doi: 10.1016/S0140-6736(12)60283-9. PMID: 22683128.
Skyler, J.S., Bakris, G.L., Bonifacio, E. et al., 2017. Differentiation of diabetes by pathophysiology, natural history, and prognosis. Diabetes. doi: 10.2337/db16-0806. PMID: 28830932.
Zaccardi, F., Webb, D.R., Yates, T. and Davies, M.J., 2016. Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective. Postgraduate Medical Journal. doi: 10.1136/postgradmedj-2015-133281. PMID: 26621825.
Powers, M.A., Bardsley, J., Cypress, M. et al., 2015. Diabetes self-management education and support in type 2 diabetes. Diabetes Care. doi: 10.2337/dc15-0730. PMID: 25998283.
Whiting, D.R., Guariguata, L., Weil, C. and Shaw, J., 2011. IDF diabetes atlas: global estimates of the prevalence of diabetes. Diabetes Research and Clinical Practice. doi: 10.1016/j.diabres.2011.03.029. PMID: 21453965.
